![]() |
|
|
PG Forkert, P Mirehouse-Brown, SS Park and HV Gelboin
Department of Anatomy, Queen's University, Kingston, Ontario, Canada.
Monoclonal antibodies specific for cytochromes P-450 induced by 3- methylcholanthrene (Mab 1-7-1) and phenobarbital (Mab 2-66-3) have been used in an unlabeled peroxidase-antiperoxidase immunohistochemical procedure to investigate the intralobular distribution and induction sites of the hemoproteins within the livers of CD-1, C57BL/6, and DBA/2 mice. 3-Methylcholanthrene-specific cytochromes P-450 were localized predominantly in centrilobular hepatocytes of control mice from all strains and were present at higher levels in CD-1 and C57BL/6 mice than in DBA/2 mice. Treatment with either 3-methylcholanthrene or beta- naphthoflavone produced striking increases of 3-methylcholanthrene- specific cytochromes P-450 in hepatocytes from all regions of the hepatic lobule in CD-1 and C57BL/6 mice, but not in DBA/2 mice. Phenobarbital-specific cytochromes P-450 were localized in hepatocytes throughout all segments of the lobule in control mice, with slightly greater hemoprotein content in centrilobular hepatocytes. Treatment with phenobarbital resulted in enhancement of cytochrome P-450 that was visualized in hepatocytes in all regions of the lobule. Strain-related differences were not observed for phenobarbital-specific cytochromes P- 450. These results demonstrate that constitutive levels of 3- methylcholanthrene- and phenobarbital-specific cytochromes P-450 are localized predominantly in centrilobular hepatocytes of murine livers, and induction of the hemoproteins is manifested to the greatest extent in periportal hepatocytes, resulting in a more uniform distribution throughout the hepatic lobule.
This article has been cited by other articles:
![]() |
R. A. Brooks, N. J. Gooderham, R. J. Edwards, A. R. Boobis, and D. J. Winton The mutagenicity of benzo[a]pyrene in mouse small intestine Carcinogenesis, January 1, 1999; 20(1): 109 - 114. [Abstract] [Full Text] [PDF] |
||||